Kai Berner
Hat mitgewirkt an:
-
Circulating microRNAs as potential diagnostic biomarkers in ovarian cancer
-
Real-world data analysis of CDK4/6 inhibitor therapy - a patient-centric single center study
-
Endoxifen and fulvestrant regulate estrogen-receptor [alpha] and related DEADbox proteins
-
Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case–control study